Literature DB >> 18234429

Inter- and intrafractional movement-induced dose reduction of prostate target volume in proton beam treatment.

Myonggeun Yoon1, Dongwook Kim, Dong Ho Shin, Sung Yong Park, Se Byeong Lee, Dae Yong Kim, Joo Young Kim, Hong Ryull Pyo, Kwan Ho Cho.   

Abstract

PURPOSE: To quantify proton radiotherapy dose reduction in the prostate target volume because of the three-dimensional movement of the prostate based on an analysis of dose-volume histograms (DVHs). METHODS AND MATERIALS: Twelve prostate cancer patients underwent scanning in supine position, and a target contour was delineated for each using a proton treatment planning system. To simulate target movement, the contour was displaced from 3 to 15 mm in 3-mm intervals in the superior-to-inferior (SI), inferior-to-superior (IS), anterior-to-posterior (AP), posterior-to-anterior (PA), and left-to-right (LR) directions.
RESULTS: For both intra- and interfractional movements, the average coverage index and conformity index of the target were reduced in all directions. For interfractional movements, the magnitude of dose reduction was greater in the LR direction than in the AP, PA, SI. and IS directions. Although the reduction of target dose was proportional to the magnitude of intrafractional movement in all directions, a proportionality between dose reduction and the magnitude of interfractional target movement was clear only in the LR direction. Like the coverage index and conformity index, the equivalent uniform dose and homogeneity index showed similar reductions for both types of target movements.
CONCLUSIONS: Small target movements can significantly reduce target proton radiotherapy dose during treatment of prostate cancer patients. Attention should be given to interfractional target movement along the longitudinal direction, as image-guided radiotherapy may be ineffective if margins are not sufficient.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18234429     DOI: 10.1016/j.ijrobp.2007.11.031

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  13 in total

1.  A Prospective Comparison of the Effects of Interfractional Variations on Proton Therapy and Intensity Modulated Radiation Therapy for Prostate Cancer.

Authors:  Maryam Moteabbed; Alexei Trofimov; Gregory C Sharp; Yi Wang; Anthony L Zietman; Jason A Efstathiou; Hsiao-Ming Lu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-12-29       Impact factor: 7.038

2.  A beam-specific planning target volume (PTV) design for proton therapy to account for setup and range uncertainties.

Authors:  Peter C Park; X Ronald Zhu; Andrew K Lee; Narayan Sahoo; Adam D Melancon; Lifei Zhang; Lei Dong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-06-22       Impact factor: 7.038

3.  Displacements of fiducial markers in patients with prostate cancer treated with image guided radiotherapy: A single-institution descriptive study.

Authors:  Ricardo Cendales; Felipe Torres; Juan Arbelaez; Armando Gaitan; Jaider Vasquez; Ivan Bobadilla
Journal:  Rep Pract Oncol Radiother       Date:  2014-09-01

4.  Interfractional variations in the setup of pelvic bony anatomy and soft tissue, and their implications on the delivery of proton therapy for localized prostate cancer.

Authors:  Alexei Trofimov; Paul L Nguyen; Jason A Efstathiou; Yi Wang; Hsiao-Ming Lu; Martijn Engelsman; Scott Merrick; Chee-Wai Cheng; James R Wong; Anthony L Zietman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-10-13       Impact factor: 7.038

Review 5.  Clinical controversies: proton therapy for prostate cancer.

Authors:  Kent W Mouw; Alexei Trofimov; Anthony L Zietman; Jason A Efstathiou
Journal:  Semin Radiat Oncol       Date:  2013-04       Impact factor: 5.934

6.  Fast range-corrected proton dose approximation method using prior dose distribution.

Authors:  Peter C Park; Joey Cheung; X Ronald Zhu; Narayan Sahoo; Laurence Court; Lei Dong
Journal:  Phys Med Biol       Date:  2012-05-16       Impact factor: 3.609

7.  IMRT, RapidArc® and conformal radiotherapy in the treatment of tumours of the anal canal.

Authors:  Ricardo Cendales; Jaider Vásquez; Juan Arbelaez; Ivan Bobadilla; Felipe Torres; Armando Gaitan
Journal:  Ecancermedicalscience       Date:  2014-10-06

8.  A simulation study on the dosimetric benefit of real-time motion compensation in spot-scanning proton therapy for prostate.

Authors:  Yusuke Fujii; Taeko Matsuura; Seishin Takao; Yuka Matsuzaki; Takaaki Fujii; Naoki Miyamoto; Kikuo Umegaki; Kentaro Nishioka; Shinichi Shimizu; Hiroki Shirato
Journal:  J Radiat Res       Date:  2017-07-01       Impact factor: 2.724

Review 9.  Proton therapy for early stage prostate cancer: is there a case?

Authors:  Tabitha Y Chan; Poh Wee Tan; Johann I Tang
Journal:  Onco Targets Ther       Date:  2016-09-09       Impact factor: 4.147

10.  Compensation method for respiratory motion in proton treatment planning for mobile liver cancer.

Authors:  Hojin Jeong; Se Byeong Lee; Seung Hoon Yoo; Young Kyung Lim; Tae Hyun Kim; Seyjoon Park; Gyu Young Chai; Ki Mun Kang; Dongho Shin
Journal:  J Appl Clin Med Phys       Date:  2013-03-04       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.